TP53 and cancer: In another prospective study, Gormally et al. found that two years before the cancer was diagnosed, KRAS (KRAS proto-oncogene, GTPase) and TP53 (tumor protein p53) mutations had been detected in the cfDNA of healthy individuals [46].